Literature DB >> 18054059

Neutralization of two North American coral snake venoms with United States and Mexican antivenoms.

Elda E Sánchez1, Juan C Lopez-Johnston, Alexis Rodríguez-Acosta, John C Pérez.   

Abstract

Elapid snakes throughout the world are considered very lethal, containing neurotoxic venoms that affect the nervous system. When humans are envenomated it is considered a serious medical emergency, and antivenom is the main form of treatment considered, in spite of the fact that some patients may only survive under intensive therapy treatment such as respiratory support. Coral snakes are part of the family Elapidae and envenomations by these snakes are very low (<2% of total snakebites) in most countries from southeastern United States to Argentina. In the United States, there are only two species of coral snakes of medical importance that belong to the Micrurus genera: Micrurus fulvius fulvius (Eastern coral snake) and Micrurus tener tener (Texas coral snake). In 2006, Wyeth pharmaceutical notified customers that the production of the North American coral snake antivenin (NACSA) in the US was discontinued and adequate supplies were available to meet historical needs through the end of October 2008; and therefore, it is of utmost important to consider other antivenoms as alternatives for the treatment of coral snake envenoming. One logical alternative is the coral snake antivenom, Coralmyn, produced by the Mexican company, Bioclon. In order to compare neutralization between NACSA and Coralmyn antivenoms with the North American coral snake venoms, the venom lethal doses (LD(50)) and antivenom effective doses (ED(50)) were determined in 18-20 g, female, BALB/c mice. Additionally, venom comparisons were determined through a non-reduced SDS-PAGE for M.f.fulvius, M.t.tener and the Mexican coral snake venom, Micrurus nigrocinctus nigrocinctus. Coralmyn antivenom was able to effectively neutralize three LD(50) doses of all venom from both M.t.tener and M.f.fulvius, while Wyeth antivenom only neutralized M.f.fulvius venom and was not effective in neutralizing three LD(50) doses of M.t.tener venom. Coralmyn is effective in the neutralization of both clinically important coral snake venoms in the US.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054059      PMCID: PMC3293456          DOI: 10.1016/j.toxicon.2007.10.004

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  29 in total

1.  The efficacy of two antivenoms against the venom of North American snakes.

Authors:  Elda E Sánchez; Jacob A Galán; John C Perez; Alexis Rodríguez-Acosta; Peter B Chase; John C Pérez
Journal:  Toxicon       Date:  2003-03-01       Impact factor: 3.033

2.  Elapid neurotoxins and their mode of action.

Authors:  C Y Lee
Journal:  Clin Toxicol       Date:  1970-09       Impact factor: 4.467

3.  Bites by coral snakes: report of 11 representative cases.

Authors:  H M Parrish; M S Khan
Journal:  Am J Med Sci       Date:  1967-05       Impact factor: 2.378

4.  Coral snake venoms. In vitro relation of neutralizing and precipitating antibodies.

Authors:  P Cohen; W H Berkeley; E B Seligmann
Journal:  Am J Trop Med Hyg       Date:  1971-07       Impact factor: 2.345

5.  Texas coral snake (Micrurus tener) bites.

Authors:  David L Morgan; Douglas J Borys; Rhandi Stanford; Dean Kjar; William Tobleman
Journal:  South Med J       Date:  2007-02       Impact factor: 0.954

Review 6.  Efficacy, safety, and use of snake antivenoms in the United States.

Authors:  R C Dart; J McNally
Journal:  Ann Emerg Med       Date:  2001-02       Impact factor: 5.721

7.  Australian tiger snake (Notechis scutatus) and mexican coral snake (Micruris species) antivenoms prevent death from United States coral snake (Micrurus fulvius fulvius) venom in a mouse model.

Authors:  Michael S Wisniewski; Robert E Hill; Joshua M Havey; Gregory M Bogdan; Richard C Dart
Journal:  J Toxicol Clin Toxicol       Date:  2003

8.  Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes.

Authors:  Viviana Arce; Ermila Rojas; Charlotte L Ownby; Gustavo Rojas; José María Gutiérrez
Journal:  Toxicon       Date:  2003-06       Impact factor: 3.033

9.  Cross-neutralization of Micrurus fulvius fulvius (coral snake) venom by anti-Micrurus carinicauda dumerilii serum.

Authors:  P Cohen; J H Dawson; E B Seligmann
Journal:  Am J Trop Med Hyg       Date:  1968-03       Impact factor: 2.345

10.  Effectiveness of two common antivenoms for North, Central, and South American Micrurus envenomations.

Authors:  Adolfo R de Roodt; Jorge F Paniagua-Solis; Jorge A Dolab; Judith Estévez-Ramiréz; Blanca Ramos-Cerrillo; Silvana Litwin; José C Dokmetjian; Alejandro Alagón
Journal:  J Toxicol Clin Toxicol       Date:  2004
View more
  9 in total

1.  First reported case of African Viper bite treated with Indian Polyvalent Anti Snake Venom.

Authors:  A Sagar; D C Joshi
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  The binding effectiveness of anti-r-disintegrin polyclonal antibodies against disintegrins and PII and PIII metalloproteases: An immunological survey of type A, B and A+B venoms from Mohave rattlesnakes.

Authors:  Esteban Cantú; Sahiti Mallela; Matthew Nyguen; Raúl Báez; Victoria Parra; Rachel Johnson; Kyle Wilson; Montamas Suntravat; Sara Lucena; Alexis Rodríguez-Acosta; Elda E Sánchez
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2016-10-28       Impact factor: 3.228

3.  Contribution of endothelial cell and macrophage activation in the alterations induced by the venom of Micrurus tener tener in C57BL/6 mice.

Authors:  Emelyn Salazar; Ana María Salazar; Peter Taylor; Izaskun Urdanibia; Karin Pérez; Alexis Rodríguez-Acosta; Elda E Sánchez; Belsy Guerrero
Journal:  Mol Immunol       Date:  2019-10-07       Impact factor: 4.407

4.  Thousands of microsatellite loci from the venomous coralsnake Micrurus fulvius and variability of select loci across populations and related species.

Authors:  Todd A Castoe; Jeffrey W Streicher; Jesse M Meik; Matthew J Ingrasci; Alexander W Poole; A P Jason de Koning; Jonathan A Campbell; Christopher L Parkinson; Eric N Smith; David D Pollock
Journal:  Mol Ecol Resour       Date:  2012-09-01       Impact factor: 7.090

5.  Hemostatic and toxinological diversities in venom of Micrurus tener tener, Micrurus fulvius fulvius and Micrurus isozonus coral snakes.

Authors:  Ana M Salazar; Jeilyn Vivas; Elda E Sánchez; Alexis Rodríguez-Acosta; Carlos Ibarra; Amparo Gil; Zoila Carvajal; María E Girón; Amalid Estrella; Luis F Navarrete; Belsy Guerrero
Journal:  Toxicon       Date:  2011-05-08       Impact factor: 3.033

6.  The Bold and the Beautiful: a Neurotoxicity Comparison of New World Coral Snakes in the Micruroides and Micrurus Genera and Relative Neutralization by Antivenom.

Authors:  Daryl C Yang; James Dobson; Chip Cochran; Daniel Dashevsky; Kevin Arbuckle; Melisa Benard; Leslie Boyer; Alejandro Alagón; Iwan Hendrikx; Wayne C Hodgson; Bryan G Fry
Journal:  Neurotox Res       Date:  2017-07-03       Impact factor: 3.911

Review 7.  Inhibition of hemorragic snake venom components: old and new approaches.

Authors:  Isabella Panfoli; Daniela Calzia; Silvia Ravera; Alessandro Morelli
Journal:  Toxins (Basel)       Date:  2010-03-25       Impact factor: 4.546

8.  A polyvalent coral snake antivenom with broad neutralization capacity.

Authors:  María Carlina Castillo-Beltrán; Juan Pablo Hurtado-Gómez; Vladimir Corredor-Espinel; Francisco Javier Ruiz-Gómez
Journal:  PLoS Negl Trop Dis       Date:  2019-03-11

9.  Coral snake antivenom produced in chickens (Gallus domesticus).

Authors:  Irma Aguilar; Elda E Sánchez; María E Girón; Amalid Estrella; Belsy Guerrero; F Alexis Rodriguez-Acosta
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jan-Feb       Impact factor: 1.846

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.